ATE476973T1 - Verbindungen mit antitumorwirkung - Google Patents

Verbindungen mit antitumorwirkung

Info

Publication number
ATE476973T1
ATE476973T1 AT05707260T AT05707260T ATE476973T1 AT E476973 T1 ATE476973 T1 AT E476973T1 AT 05707260 T AT05707260 T AT 05707260T AT 05707260 T AT05707260 T AT 05707260T AT E476973 T1 ATE476973 T1 AT E476973T1
Authority
AT
Austria
Prior art keywords
compounds
antitumor effects
antitumor
effects
Prior art date
Application number
AT05707260T
Other languages
English (en)
Inventor
Gianfranco Peluso
Menotti Calvani
Original Assignee
Defiante Farmaceutica Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Defiante Farmaceutica Sa filed Critical Defiante Farmaceutica Sa
Application granted granted Critical
Publication of ATE476973T1 publication Critical patent/ATE476973T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT05707260T 2004-02-12 2005-02-08 Verbindungen mit antitumorwirkung ATE476973T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000230A ITMI20040230A1 (it) 2004-02-12 2004-02-12 Composti ad attivita' antitumorale
PCT/EP2005/001257 WO2005077354A1 (en) 2004-02-12 2005-02-08 Compounds having antitumor activity

Publications (1)

Publication Number Publication Date
ATE476973T1 true ATE476973T1 (de) 2010-08-15

Family

ID=34856910

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05707260T ATE476973T1 (de) 2004-02-12 2005-02-08 Verbindungen mit antitumorwirkung

Country Status (19)

Country Link
US (1) US7652066B2 (de)
EP (1) EP1713461B1 (de)
JP (1) JP2007522165A (de)
KR (1) KR101220331B1 (de)
CN (1) CN1917867B (de)
AR (1) AR047742A1 (de)
AT (1) ATE476973T1 (de)
AU (1) AU2005211906B2 (de)
BR (1) BRPI0507664A (de)
CA (1) CA2556069C (de)
CY (1) CY1111048T1 (de)
DE (1) DE602005022828D1 (de)
DK (1) DK1713461T3 (de)
ES (1) ES2350695T3 (de)
IT (1) ITMI20040230A1 (de)
PL (1) PL1713461T3 (de)
SI (1) SI1713461T1 (de)
TW (1) TWI361802B (de)
WO (1) WO2005077354A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8314144B2 (en) * 2004-02-12 2012-11-20 Defiante Farmaceutica, S.A. Compounds having antitumor activity
CA2680366C (en) 2007-03-09 2016-06-21 University Health Network Inhibitors of carnitine palmitoyltransferase and treating cancer
WO2009015485A1 (en) 2007-08-01 2009-02-05 University Health Network Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer
WO2009132978A1 (en) * 2008-04-29 2009-11-05 F. Hoffmann-La Roche Ag 4-dimethylaminobutyric acid derivatives
KR20110044209A (ko) * 2008-06-24 2011-04-28 다라 바이오싸이언시즈, 아이엔씨. 효소 억제제 및 그의 용도
JP5746988B2 (ja) * 2012-02-15 2015-07-08 ライオン株式会社 カプセル皮膜及びカプセル

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1299266B1 (it) * 1998-05-15 2000-02-29 Sigma Tau Ind Farmaceuti Inibitori reversibili della carnitina palmitoil trasferasi
DE60028996T2 (de) * 1999-11-12 2007-02-08 The Johns Hopkins University School Of Medicine Behandlung von krebs durch erhöhung des malonyl-coa-spiegels

Also Published As

Publication number Publication date
BRPI0507664A (pt) 2007-07-17
TWI361802B (en) 2012-04-11
US20080227683A1 (en) 2008-09-18
CN1917867B (zh) 2011-03-16
TW200530154A (en) 2005-09-16
ITMI20040230A1 (it) 2004-05-12
KR20060134059A (ko) 2006-12-27
CA2556069A1 (en) 2005-08-25
DK1713461T3 (da) 2010-11-22
CA2556069C (en) 2013-04-23
AU2005211906A1 (en) 2005-08-25
EP1713461B1 (de) 2010-08-11
HK1099687A1 (en) 2007-08-24
ES2350695T3 (es) 2011-01-26
WO2005077354A1 (en) 2005-08-25
US7652066B2 (en) 2010-01-26
AU2005211906B2 (en) 2009-07-30
KR101220331B1 (ko) 2013-01-09
DE602005022828D1 (de) 2010-09-23
AR047742A1 (es) 2006-02-15
EP1713461A1 (de) 2006-10-25
CY1111048T1 (el) 2015-06-11
PL1713461T3 (pl) 2011-01-31
SI1713461T1 (sl) 2010-12-31
CN1917867A (zh) 2007-02-21
JP2007522165A (ja) 2007-08-09

Similar Documents

Publication Publication Date Title
ATE516293T1 (de) Antivirale verbindungen
NO20161521L (no) Antivirale forbindelser
EP1711739A4 (de) Direkt zu sehende leuchte
ATE437875T1 (de) Heterozyklische antivirale verbindungen
DE502005002342D1 (de) Lichtemittierendes Bauelement
FR2869475B1 (fr) Resolveur
ATE522514T1 (de) Dihydropyran-2-onverbindungen mit antitumorwirkung
DE602005023694D1 (de) Flachbildschirm mit reduziertem Übersprechen
DE602006018341D1 (de) Antihypercholesterinämische verbindungen
DE502006007719D1 (de) Rektoskop mit lichtabstrahlenden Elementen
EP1875777A4 (de) Lichtemittierendes bauelement
DK1839662T3 (da) Antitumormiddel
DE602006003830D1 (de) Fahrzeug mit erhöhter wahrgenommener Genauigkeit
EP1745187A4 (de) Schlösser
DE602005022828D1 (de) Verbindungen mit antitumorwirkung
DE502005006235D1 (de) Zahnradanordnung
DE602005010518D1 (de) Reifenvulkanisierblase
DE602006016564D1 (de) Neue cyclische verbindung mit chinolylalkylthiogruppe
EE00444U1 (et) Fosforiühend
ATE384719T1 (de) Dioxazinyl-substituierte thienylsulfonylaminocarbonylverbindungen
SI1778702T1 (sl) Protivirusne spojine
DE102004003929B8 (de) Mit SM-Technologie bestückbares optoelektronisches Bauelement
ES1059168Y (es) Bicicleta.
ATE494349T1 (de) Phosphoreszierende verbindungen
SE0401067D0 (sv) Ett av en operatör bärbart arrangemang

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1713461

Country of ref document: EP